Conditions: Diabetes Mellitus, Type 1
Keywords: Phase 1 RN168 Adults Type 1 Diabetes T1D
Allocation: RANDOMIZED | Intervention model: 
Enrollment: 37
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of multiple doses of PF-06342674. Several dose levels will be evaluated.

Detailed description:

Arms:
arm 1: Placebo arm 2: None

Interventions: intervention 1: Placebo intervention 2: PF-06342674 Dose A intervention 3: PF-06342674 Dose B intervention 4: PF-06342674 Dose C intervention 5: PF-06342674 Dose D
Intervention descriptions: intervention 1: Placebo intervention 2: Multiple SC Doses intervention 3: Multiple SC Doses intervention 4: Multiple SC Doses intervention 5: Multiple SC Doses

Protocol document: